Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Fortunato O, Huber V, Segale M, Cova A, Vallacchi V, Squarcina P, Rivoltini L, Suatoni P, Sozzi G, Pastorino U, Boeri M. Fortunato O, et al. Among authors: huber v. Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2020-2029. doi: 10.1158/1055-9965.EPI-22-0689. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36112827 Free PMC article.
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.
Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, Stringaro A, Molinari A, Arancia G, Gentile M, Parmiani G, Fais S. Andreola G, et al. Among authors: huber v. J Exp Med. 2002 May 20;195(10):1303-16. doi: 10.1084/jem.20011624. J Exp Med. 2002. PMID: 12021310 Free PMC article.
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.
Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S, Parmiani G. Rivoltini L, et al. Among authors: huber v. Immunol Rev. 2002 Oct;188:97-113. doi: 10.1034/j.1600-065x.2002.18809.x. Immunol Rev. 2002. PMID: 12445284 Review.
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.
Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G, Scheibenbogen C, Squarcina P, Cova A, Camerini R, Lewis JJ, Srivastava PK, Parmiani G. Rivoltini L, et al. Among authors: huber v. J Immunol. 2003 Oct 1;171(7):3467-74. doi: 10.4049/jimmunol.171.7.3467. J Immunol. 2003. PMID: 14500642
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?
Rivoltini L, Canese P, Huber V, Iero M, Pilla L, Valenti R, Fais S, Lozupone F, Casati C, Castelli C, Parmiani G. Rivoltini L, et al. Among authors: huber v. Expert Opin Biol Ther. 2005 Apr;5(4):463-76. doi: 10.1517/14712598.5.4.463. Expert Opin Biol Ther. 2005. PMID: 15934826 Review.
Tumor-released microvesicles as vehicles of immunosuppression.
Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Valenti R, et al. Among authors: huber v. Cancer Res. 2007 Apr 1;67(7):2912-5. doi: 10.1158/0008-5472.CAN-07-0520. Cancer Res. 2007. PMID: 17409393 Review.
215 results